1. Volova L.T., Trunin D.M., Ponomareva Yu.Ya., Popov N.V. Issledovanie biosovmestimosti i tsitotoksichnosti personifitsirovannykh kostnykh implantatov s primeneniem kletochnykh tekhnologii [assessment of biocompatibility and cytotoxicity of personalized bone implants using cell cultures]. Vestnik meditsinskogo instituta «REAVIZ» (Reabilitatsiya, vrach i zdorov’e), 2017, no. 5, pp. 32–39.
2. Teplyashin A.S., Sharifullina S.Z., Chupikova N.I., Sepiashvili R.I. Perspektivy ispol’zovaniya mul’tipotentnykh stvolovykh kletok kostnogo mozga i zhirovoi tkani v regulyatsii regeneratsii opornykh tkanei [Prospects for the use of multipotent stem cells of bone marrow and adipose tissue in the regulation of regeneration of supporting tissues]. Allergologiya i immunologiya, 2015, vol. 1, no. 6, pp. 138–148.
3. Athanasiou V.T., Papachristou D.J., Panagopoulos A. et al. Histological comparison of autograft, allograft-DBM, xenograft, and synthetic grafts in a trabecular bone defect: An experimental study in rabbits. Med Sci Monit, 2010, vol. 6(1), pp. 24–31. PMID: 20037482.
4. Bartholomew A., Polchert D., Szilagyi E. et al. Mesenchymal stem cells in the induction of transplantation tolerance. Transplantation, 2009, vol. 87(9), pp. 55–57. DOI: 10.1097/TP.0b013e3181a287e6.
5. Blanco J.F., Villarón E.M., Pescador D. et al. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Res Ther, 2019, vol. 10(1), p. 63. DOI: 10.1186/s13287-019-1166-4.